rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

22 Jul,14:39
2616.95
46.25 (1.80%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

3,771 2,570.70 2,652.10 - 2,545.15 2,759.00 - 1,376.50 44,331.14
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

22 Jul,14:43
2617.00
43.85 (1.70%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

159,927 2573.15 2,655.00 - 2,551.00 2,760.00 - 1,377.25 4,177.09
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Jakson Green...
Jakson Green Secures Rs 296 Cr Credit for Uzbekistan Solar Project
Jakson Green has secured a Rs 296 crore credit facility from First Abu Dhabi Bank to expand its international business, starting with a solar project in Uzbekistan.
Jul 22, 2024 14:38
India's Export...
India's Export Growth: Services &' Diversification &' | Economic Survey
India&'s export destinations are diversifying, with services exports expanding significantly. Learn about the key trends and growth drivers in India&'s export sector.
Jul 22, 2024 14:36
Union Budget...
Union Budget 2024: Massive Capital Expenditure Focus - Expert
Expert predicts a significant increase in capital expenditure in the upcoming Union Budget, focusing on infrastructure, manufacturing, green energy and more. Learn about potential growth drivers...
Jul 22, 2024 14:31
Clean Coal...
Clean Coal Initiatives: Eco Survey Urges Promotion
India's Economic Survey emphasizes promoting cleaner coal technologies like gasification and coal-to-hydrogen to reduce emissions and achieve energy security.
Jul 22, 2024 14:20
Real Estate...
Real Estate Outlook Encouraging: Economic Survey
India's Economic Survey forecasts a positive outlook for the real estate sector driven by urbanization and rising housing demand, but highlights stalled projects as a challenge.
Jul 22, 2024 14:19

More News »

Top News

Jakson Green...
Jakson Green Secures Rs 296 Cr Credit for Uzbekistan Solar Project
Jakson Green has secured a Rs 296 crore credit facility from First Abu Dhabi Bank to expand its international business, starting with a solar project in Uzbekistan.
Jul 22, 2024 14:38
India's Fiscal...
India's Fiscal Balance Improved Despite Public Investment: Economic Survey
India's fiscal balances improved despite public investments, driven by tax compliance gains and expenditure restraint, according to the Economic Survey 2023-24.
Jul 22, 2024 14:38
India's Export...
India's Export Growth: Services &' Diversification &' | Economic Survey
India&'s export destinations are diversifying, with services exports expanding significantly. Learn about the key trends and growth drivers in India&'s export sector.
Jul 22, 2024 14:36
India's Renewable...
India's Renewable Energy Sector to Attract Rs 30.5 Lakh Cr Investment by 2030
India's renewable energy sector is set to attract investments worth Rs 30.5 lakh crore by 2030, driven by the government's ambitious target of 500GW renewable energy by 2030. The Economic Survey...
Jul 22, 2024 14:33
Union Budget...
Union Budget 2024: Massive Capital Expenditure Focus - Expert
Expert predicts a significant increase in capital expenditure in the upcoming Union Budget, focusing on infrastructure, manufacturing, green energy and more. Learn about potential growth drivers...
Jul 22, 2024 14:31

More Top News »

Report Card

PE Ratios
74.48
EPS (Rs.)
34.51
Sales (Rs. Cr)
910.87
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
320
Return on Average Equity
32.6

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Most Active

  • Change (Rs.)
  •  

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close